Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korean Government Fines Five Pharma Multinationals For Unfair Trade

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's trade watchdog, the Fair Trade Commission, has imposed fines collectively totaling KRW 20.48 billion ($14.8 million) on seven pharmaceutical companies - including five multinationals - on charges of unfair provision of rebates and other improper benefits to doctors and hospitals
Advertisement

Related Content

Korea's Antitrust Watchdog Says Rebates Continuing Despite New Law; Levies $11 Million In Fines
Korea's Antitrust Watchdog Says Rebates Continuing Despite New Law; Levies $11 Million In Fines
Four Major South Korean Hospitals Are Penalized For Soliciting "Donations" From Pharmaceutical Outfits Including MNCs
Merck and Pfizer Going To Court Over Korea FTC Fines; Lilly And GSK Watch From The Sidelines
Korea Pharmaceutical Manufacturers Association President Under Fire For Alleged Kickbacks
South Korea’s FTC Looking Into Sanofi Aventis and Novartis For Price Inflation – Industry Insiders
Merck And Hanmi Partner In First Of A Kind Deal In South Korea
Korea Pharma Manufacturing Association Takes Steps To Snag Unethical Member Companies
MNCs Urge Indonesia For Exemption From Decree Requiring Local Manufacturing Facilities
MNCs Urge Indonesia For Exemption From Decree Requiring Local Manufacturing Facilities
Advertisement
UsernamePublicRestriction

Register

SC069852

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel